Skip to main content

Advertisement

SpringerLink
Log in

A correlation between serum immunosuppressive acidic protein and altered immunocompetence in patients with brain tumours

  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Summary

The present investigation was conducted to document a correlation between the serum levels of immunosuppressive acidic protein (IAP) and depressed lymphocyte responsiveness to mitogens in vitro in patients with intracranial tumours, and to delineate the possible roles of IAP upon immunocompetence in these patients. It was thought that high concentrations of IAP present in the serum of brain-tumour patients may play a significant role in the immunosuppression seen in this patient population. The effect of IAP upon mitogen-stimulated lymphocyte function was evaluated by tritiated (3H)-thymidine incorporation. Lymphocytes from both 30 patients with intracranial tumours and 30 normal individuals were incubated for 90 hours in culture medium in the presence of three mitogens: phytohaemagglutinin (PHA), concanavalin A (Con A), and pokeweed mitogen (PWM). Lymphocytes obtained from patients with brain tumours and cultured in autologous serum displayed a significant depression of3H-thymidine incorporation, as was observed in previous studies. In addition, a significant suppression of mitogen-induced activation of the normal lymphocytes was demonstrated in the presence of allogeneic patients' serum and the percentage of inhibition was found significantly proportional to the IAP concentrations. Furthermore it was also demonstrated that increased levels of serum IAP could significantly correlate with two in vivo aspects of impaired cellular immunity: the decreased lymphocyte counts in the peripheral blood and diminished cutaneous delayed hypersensitivity reactions measured by purified protein derivative (PPD) skin test reactivity. On the other hand, an attempt was also made to investigate changes in humoral immunity and immunoglobulin concentrations were observed not to correspond to the serum IAP levels. These studies suggest a possible connection between serum IAP levels and altered cellular immune competence in brain-tumour patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Brooks WH, Caldwell HD, Mortara RH (1974) Immune responses in patients with gliomas. Surg Neurol 2: 419–423

    Google Scholar 

  2. Brooks WH, Netsky MG, Normansell DE, Horwitz DA (1972) Depressed cell-mediated immunity in patients with primary intracranial tumors: Characterization of a humoral immunosuppressive factor. J Exp Med 136: 1631–1647

    Article  PubMed  Google Scholar 

  3. Cheresh DA, Distasio JA, Vogel CL, Lopez DM (1982) Mitogen-induced blastogenesis and receptor mobility inhibition by breast cancer serum with elevated orosomucoid (α1-acid glycoprotein) levels. JNCI 68: 779–783

    PubMed  Google Scholar 

  4. Cheresh DA, Haynes DH, Distasio JA (1984) Interaction of an acute phase reactant, α1-acid glycoprotein (orosomucoid), with the lymphoid cell surface: a model for non-specific immune suppression. Immunology 51: 541–548

    PubMed  Google Scholar 

  5. Chiu KM, Mortensen RF, Osmond AP, Gewurz H (1977) Interaction of alpha-acid glycoprotein with the immune system. Immunology 32: 997–1005

    PubMed  Google Scholar 

  6. De Martin R, Haendler B, Hofer-Warbinek R, Gaugitsh H, Wrann M, Schlüsener H, Seifert JM, Bodmer S, Fontana A, Hofer E (1987) Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-β gene family. EMBO J 6: 3673–3677

    PubMed  Google Scholar 

  7. Dillman RO, Koziol JA, Zavanelli MI, Beauregard JC, Halliburton BL, Glassy MC, Royston I (1984) Immunocompetence in cancer patients. Assessment by in vitro stimulation tests and quantification of lymphocyte subpopulations. Cancer 53: 1484–1491

    PubMed  Google Scholar 

  8. Engelman EG, Warnke R, Fox RI, Dilley J, Benike CJ, Levy R (1981) Studies of a human T lymphocyte antigen recognized by a monoclonal antibody. Proc Natl Acad Sci USA 78: 1791–1795

    PubMed  Google Scholar 

  9. Fontana A, Hengartner H, de Tribolet N, Weber E (1984) Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects. J Immunol 132: 1837–1844

    PubMed  Google Scholar 

  10. Ganz PA, Shell WE, Tokes ZA (1983) Elevation of a radioimmunoassay for α1-acid glycoprotein to monitor therapy of cancer patients. JNCI 71: 25–30

    PubMed  Google Scholar 

  11. Harvey HA, Lipton A, Serra DA, Albright C, DeLong S, Davidson EA (1978) Inhibition of in vitro lymphocyte function by α1 acid glycoprotein, tumor related glycoprotein and fibrinogen degeneration products. Proc Am Assoc Cancer Res 19: 24

    Google Scholar 

  12. Hoffman RA, Kung PC, Hansen WP, Goldstein G (1980) Simple and rapid measurement of human T lymphocytes and their subclasses in peripheral blood. Proc Natl Acad Sci USA 77: 4914–4917

    PubMed  Google Scholar 

  13. Ishida N, Shibata Y, Tamura K (1982) Serum protein factors against self defense which are activated in cancer patients. In: Mizuno D, Cohn ZA, Takeya K, Ishida N (eds) Self-defense mechanisms. Role of macrophages. University of Tokyo Press, Tokyo, pp 239–250

    Google Scholar 

  14. Israel L, Edelstein R (1978) In vivo and in vitro studies on nonspecific blocking factors of host origin in cancer patients. Israel J Med Sci 14: 105–130

    PubMed  Google Scholar 

  15. Karavodin LM, Giuliano AE, Golub SH (1981) T lymphocyte subsets in patients with malignant melanoma. Cancer Immunol Immunother 11: 251–254

    Google Scholar 

  16. Kikuchi K, Neuwelt EA (1983) Presence of immunosuppressive factors in brain-tumor cyst fluid. J Neurosurg 59: 790–799

    PubMed  Google Scholar 

  17. Kikuchi K, McCormick CI, Neuwelt EA (1984) Immuno-suppression by phenytoin: implication for altered immune competence in brain-tumor patients. J Neurosurg 61: 1085–1090

    PubMed  Google Scholar 

  18. Kikuchi K, Gotoh H, Kowada M (1987) Immunosuppressive acidic protein in patients with brain tumours: a preliminary report. Acta Neurochir (Wien) 86: 42–49

    Google Scholar 

  19. Mancini G, Carbonara AP, Hermans JE (1965) Immunochemical quantitation of antigen by single radial immunodiffusion. Immunochemistry 2: 235–254

    Article  PubMed  Google Scholar 

  20. Matsuura H, Nakazawa S (1985) Prognostic significance of serum α1-acid glycoprotein in patients with glioblastoma multiforme: a preliminary communication. J Neurol Neurosurg Psychiatry 48: 835–837

    PubMed  Google Scholar 

  21. McKeever PE, Quindlen E, Banks MA, Williams U, Kornblith PL, Laverson S, Greenwood MA, Smith B (1981) Biosynthesized products of cultured neuroglial cells: I. Selective release of proteins by cells from human astrocytomas. Neurology 31: 1445–1452

    PubMed  Google Scholar 

  22. Neuwelt EA, Kikuchi K, Hill S, Lipsky P, Frenkel EP (1983) Immune responses in patients with brain tumors. Factors such as anti-convulsants that may contribute to impaired cell-mediated immunity. Cancer 51: 248–255

    PubMed  Google Scholar 

  23. Roszman TL, Brooks WH (1980) Immunobiology of primary intracranial tumours. III. Demonstration of a qualitative lymphocyte abnormality in patients with primary brain tumours. Clin Exp Immunol 39: 395–402

    PubMed  Google Scholar 

  24. Sawada M, Okudaira Y, Matsui Y, Shimizu Y (1983) Immunosuppressive acidic protein in patients with ovarian cancer. Cancer 52: 2081–2085

    PubMed  Google Scholar 

  25. Sawada M, Okudaira Y, Matsui Y (1984) Immunosuppressive acidic protein in patients with gynecologic cancer. Cancer 54: 652–656

    PubMed  Google Scholar 

  26. Shibata Y, Tamura K, Ishida N (1983) In vivo analysis of the suppressive effects of immunosuppresive acidic protein, a type of α1-acid glycoprotein, in connection with its high level in tumor-bearing mice. Cancer Res 43: 2889–2896

    PubMed  Google Scholar 

  27. Tamura K, Shibata Y, Matsuda Y, Ishida N (1981) Isolation and characterization of an immunosuppressive acidic protein from ascitic fluids of cancer patients. Cancer Res 41: 3244–3252

    PubMed  Google Scholar 

  28. Thomas DGT, Lannigan CB, Behan PO (1975) Impaired cell-mediated immunity in human brain tumours. Lancet 1: 1389–1390

    PubMed  Google Scholar 

  29. Thompson DK, Haddow JE, Smith DE, Ritchie RF (1983) Elevated serum acute phase protein levels as predictors of disseminated breast cancer. Cancer 51: 2100–2104

    PubMed  Google Scholar 

  30. Weiss JF, Morantz RA, Bradley WP, Chretien PB (1979) Serum acute-phase proteins and immunoglobulins in patients with gliomas. Cancer Res 39: 542–544

    PubMed  Google Scholar 

  31. Yoshida S, Kara N, Takai N, Saito T, Tanaka R (1985) Clinicoimmunological values of management of IgG Fc receptor positive T cells in patients with malignant brain tumors. Brain Nerve (Tokyo) 37: 1073–1078

    Google Scholar 

  32. Young HF, Sakalas R, Kaplan AM (1976) Immunological depression in cerebral gliomas. In: Thompson RA, Green JR (eds) Advances in neurology, vol 15. Raven Press, New York, pp 327–335

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Akita University School of Medicine, Akita, Japan

    K. Kikuchi, H. Gotoh & M. Kowada

Authors
  1. K. Kikuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Gotoh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Kowada
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kikuchi, K., Gotoh, H. & Kowada, M. A correlation between serum immunosuppressive acidic protein and altered immunocompetence in patients with brain tumours. Acta neurochir 103, 52–61 (1990). https://doi.org/10.1007/BF01420192

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01420192

Keywords

Search

Navigation